An act relating to toxic heavy metals in baby food products
H.536 would regulate baby food products sold or distributed in Vermont by prohibiting the sale of any product that contains toxic heavy metals above U.S. Food and Drug Administration limits. The bill defines toxic heavy metals as arsenic, cadmium, lead, and mercury, and it excludes infant formula from the initial baby-food provisions. It also requires manufacturers to test representative samples from each production aggregate at least monthly using a proficient laboratory, and to retain and provide test results to state officials upon request.
The bill further requires manufacturers to make testing information publicly available on their websites, including the levels of each toxic heavy metal found, product-identifying information, and links to FDA guidance on the health effects of toxic metals in children. For products subject to FDA action levels or tolerances, the bill requires on-package disclosure that more information is available via QR code or another machine-readable code that links consumers to the manufacturer’s testing information and FDA resources. Violations are treated as violations of Vermont’s Consumer Protection Act, giving the Attorney General enforcement authority and private parties the same remedies available under that law.
The bill would add a new section to Vermont’s food-labeling laws in 18 V.S.A. chapter 82 and create a parallel framework for infant formula in 18 V.S.A. § 4091, with the infant-formula provisions delayed until comparable laws are enacted in California or two other states. It would impose new testing, disclosure, and labeling obligations on baby food manufacturers and retailers, and it would authorize enforcement through the Consumer Protection Act, including civil investigations, rulemaking, assurances of discontinuance, and civil actions by the Attorney General. The bill also includes a stock-in-trade protection for existing inventory and staged effective dates, with the baby-food provisions generally taking effect January 1, 2027.
The available voting history suggests strong support for the bill: it passed third reading in the House unanimously, 28-0. The bill’s stated purpose and structure indicate a consumer-protection and child-health focus, with an emphasis on transparency and reducing exposure to toxic contaminants in foods marketed for infants and toddlers. No committee transcript is provided, so the record here shows broad legislative agreement rather than documented debate.
The main policy tension in the bill is between stronger safety disclosure requirements and the compliance burden placed on manufacturers and sellers of baby food. The bill’s testing, website disclosure, and QR-code labeling requirements could raise costs and operational complexity, especially for smaller manufacturers. A second point of contention is the treatment of infant formula: the bill initially excludes it from the baby-food prohibition, then separately adds formula-specific provisions that only take effect after comparable laws exist in other states, reflecting concern about supply disruption and federal-state coordination. The bill also contains language clarifying that it should not conflict with federal law or regulation, suggesting sensitivity to preemption issues.